Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02288117
Other study ID # 1202 HP
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 2015
Est. completion date May 2023

Study information

Verified date December 2020
Source Waldemar Link GmbH & Co. KG
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this PMCF is to collect clinical and radiographic outcome information on Total Hip Arthroplasty (THA) performed with LINK® SP-CL® Hip Prosthesis Stem under routine conditions. The results collected will be used to clinically confirm the performance and safety of the LINK® SP-CL® Hip Prosthesis Stem in terms of the manufacturer's obligation to perform a PMCF. Furthermore the results can be used for future regulatory processes if needed.


Description:

Post Market Clinical Follow-ups (PMCF) through observational studies are an important tool to detect infrequent complications or problems, events specific to defined patient populations and long term performance issues under routine conditions [2,3]. Against this background a prospective multi-center outcome study of the LINK® SP-CL® is planned.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 240
Est. completion date May 2023
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Skeletally mature - Subject agrees to comply with the required postoperative management and follow-up evaluations - Undergone at least six (6) month of unsuccessful, conservative, non-surgical treatment - Patient understands the conditions of the study and is willing and able to comply with the postoperative scheduled clinical and radiographic evaluations and the prescribed postoperative management. - Patient signed Informed Consent. Exclusion Criteria: - Body Mass Index (BMI) > 40 kg/m2 - Poor general state of health - Acute and chronic infections, local and systemic - Pharmaceutical or other drug abuse, alcoholism - Allergies to implant materials - Distinctive muscular, nerve, vascular or other diseases which put the affected limb at risk - Insufficient / inadequate bone mass- or quality which prevents a stable anchorage of the prosthesis - Severe osteoporosis - Foreseeable overload/ overstressing of the joint prosthesis - Acetabular defects - Female patient who is pregnant or plans to became pregnant during the course of the study - Prisoner - Patient who, as judged by the surgeon, is mentally incompetent or is unlikely to be compliant with the prescribed postoperative routine and follow-up evaluation schedule - Patient who has not signed the Informed Consent

Study Design


Locations

Country Name City State
Germany HELIOS ENDO-Klinik Hamburg
Germany Krankenhaus Barmherzige Brüder Regensburg Regensburg Bayern
Italy L'Istituto Ortopedico Gaetano Pini Milan
Spain Hospital Sant Rafael Barcelona

Sponsors (1)

Lead Sponsor Collaborator
Waldemar Link GmbH & Co. KG

Countries where clinical trial is conducted

Germany,  Italy,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stem Survival Rate The survival of the stem Up to 5 years
Secondary Complication Rate Number and kind of complications Up to 5 years
Secondary Reoperation Rate number of reoperations Up to 5 years
Secondary Harris Hip Score (HHS) Clinical Score to get information about the subjects pain and hip function, collected continuously Up to 5 years
Secondary Oxford Hip Score (OHS) PROM to assess function and pain after THR Up to 5 years
Secondary Forgotten Joint Score (FJS) awareness of the artificial joint Up to 2 years
Secondary Mid Thigh Pain Pain occuring in the front and mid part of the femur Up to 5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05773261 - Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups N/A
Recruiting NCT05223777 - KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA) N/A
Recruiting NCT04731077 - Avenir Complete Post-Market Clinical Follow-Up Study N/A
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT06162195 - The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement N/A
Withdrawn NCT02743208 - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty N/A
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Active, not recruiting NCT02229279 - Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures N/A
Active, not recruiting NCT02851992 - A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem N/A
Completed NCT01618708 - A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip N/A
Completed NCT01700933 - Dose-response: Exercise Therapy on Hip Osteoarthritis N/A
Completed NCT01214954 - Early Rehabilitation After Total Hip Replacement N/A
Active, not recruiting NCT00294424 - Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements N/A
Terminated NCT00588861 - Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement N/A
Withdrawn NCT05054595 - Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Recruiting NCT05014113 - H-28 DELTA ST-C and Minima Retrospective Study.
Completed NCT01066936 - Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
Recruiting NCT06185036 - Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint